1. Pallidal Deep-Brain Stimulation in Primary Generalized or Segmental Dystonia.
- Author
-
Kupsch, Andreas, Benecke, Reiner, Müller, Jörg, Trottenberg, Thomas, Schneider, Gerd-Helge, Poewe, Werner, Eisner, Wilhelm, Wolters, Alexander, Müller, Jan-Uwe, Deuschl, Günther, Pinsker, Marcus O., Skogseid, Inger Marie, Roeste, Geir Ketil, Vollmer-Haase, Juliane, Brentrup, Angela, Krause, Martin, Tronnier, Volker, Schnitzler, Alfons, Voges, Jürgen, and Nikkhah, Guido
- Subjects
- *
TREATMENT of dystonia , *BRAIN stimulation , *CLINICAL trials , *MEDICAL research , *NEURAL stimulation , *ARTICULATION disorders , *QUALITY of life - Abstract
Background: Neurostimulation of the internal globus pallidus has been shown to be effective in reducing symptoms of primary dystonia. We compared this surgical treatment with sham stimulation in a randomized, controlled clinical trial. Methods: Forty patients with primary segmental or generalized dystonia received an implanted device for deep-brain stimulation and were randomly assigned to receive either neurostimulation or sham stimulation for 3 months. The primary end point was the change from baseline to 3 months in the severity of symptoms, according to the movement subscore on the Burke–Fahn–Marsden Dystonia Rating Scale (range, 0 to 120, with higher scores indicating greater impairment). Two investigators who were unaware of treatment status assessed the severity of dystonia by reviewing videotaped sessions. Subsequently, all patients received open-label neurostimulation; blinded assessment was repeated after 6 months of active treatment. Results: Three months after randomization, the change from baseline in the mean (±SD) movement score was significantly greater in the neurostimulation group (−15.8±14.1 points) than in the sham-stimulation group (−1.4±3.8 points, P<0.001). During the open-label extension period, this improvement was sustained among patients originally assigned to the neurostimulation group, and patients in the sham-stimulation group had a similar benefit when they switched to active treatment. The combined analysis of the entire cohort after 6 months of neurostimulation revealed substantial improvement in all movement symptoms (except speech and swallowing), the level of disability, and quality of life, as compared with baseline scores. A total of 22 adverse events occurred in 19 patients, including 4 infections at the stimulator site and 1 lead dislodgment. The most frequent adverse event was dysarthria. Conclusions: Bilateral pallidal neurostimulation for 3 months was more effective than sham stimulation in patients with primary generalized or segmental dystonia. (ClinicalTrials.gov number, NCT00142259.) N Engl J Med 2006;355:1978-90. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF